BioAtla, Inc. (BCAB) vs Cullinan Therapeutics, Inc. (CGEM)
Detailed comparison between BioAtla, Inc., Cullinan Therapeutics, Inc..Total Return (%)
BioAtla, Inc. (BCAB)Cullinan Therapeutics, Inc. (CGEM)
Which stock do you think will perform better?
BioAtla, Inc.
BCAB
Cullinan Therapeutics, Inc.
CGEM
| Metric | BioAtla, Inc. (BCAB) | Cullinan Therapeutics, Inc. (CGEM) |
|---|---|---|
| Current Price | $0.38 | $8.72 |
| Change | -0.03 (-6.84%) | -0.31 (-3.43%) |
| Market Cap | $0.02B | $0.51B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -0.26 | -2.68 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $4.02 | $30.19 |
| 52-Week Low | $0.38 | $8.61 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-1.70 | $-2.84 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BCAB | -22.57% | -22.57% | -84.61% | -98.77% | -98.77% | -98.77% |
| CGEM | -15.34% | -15.34% | -51.15% | -70.85% | -70.85% | -70.85% |